Coercive Control and Intimate Partner Violence
ConditionCoercive Control
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorCentre Hospitalier Intercommunal Robert Ballanger
About this trial
Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care.
The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
Women identified as victims of intimate partner violence.
Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
No objection to participation in the study (non-opposition).
Disqualifiers
Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).
Trial design
Design model
Single group
Treatments tested in this trial
questionnaire
Other interventionParticipants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Questionnaire armExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Coercive Control Screening Scale
Measure of Coercive Control Screening Scale (CCSS). Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
Time frame
Measure of CCSS between inlusion and month 6Secondary outcomes
1
Measure of Hospital Anxiety and Depression scale (HAD scale)
correlation between HAD scale and CCSS scale. Minimal scale = 0, maximal scale = 42. Higher score means worse outcome
Time frame
Measure of HHAD scale between inclusion and month 62
Severity of post-traumatic stress disorder symptoms
Severity of post-traumatic stress disorder (PTSD) symptoms assessed by the PTSD Checklist for DSM-5 (PCL-5), based on total score and DSM-5 clinical thresholds. Minimal scale = 0, maximal scale = 80. Higher score means worse outcome
Time frame
at inclusion and month 63
International Trauma Questionnaire (ITQ).
International Trauma Questionnaire (ITQ), according to ICD-11 criteria. Minimal scale = 0, maximal scale = 72. Higher score means worse outcome
Time frame
Inclusion and month 64
Severity of emotional dysregulation
Severity of emotional dysregulation assessed using the Difficulties in Emotion Regulation Scale - French version (DERS-F). Minimal scale = 36, maximal scale = 180. Higher score means worse outcome
Time frame
inclusion and month 6Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: